Citius Pharmaceuticals, Inc. (CTXR)
0.9622
+0.09
(+10.92%)
USD |
NASDAQ |
Mar 13, 16:00
0.9525
-0.01
(-1.01%)
After-Hours: 20:00
Citius Pharmaceuticals Total Liabilities (Quarterly) : 46.92M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Citius Oncology, Inc. | 51.56M |
| Dermata Therapeutics, Inc. | 1.111M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 46.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 140.39M |
| Shareholders Equity (Quarterly) | 79.96M |
| Debt to Equity Ratio | 0.0229 |
| Current Ratio | 0.9931 |
| Net Debt Paydown Yield | -1.80% |